Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lene Nygaard Axelsen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|November 21, 2024
Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertensionLene Nygaard Axelsen, Anne Kümmel, Juan Jose Perez Ruixo, et al.
British Journal of Clinical Pharmacology|May 17, 2020
Clopidogrel, a CYP2C8 inhibitor, causes a clinically relevant increase in the systemic exposure to the active metabolite of selexipag in healthy subjectsLene Nygaard Axelsen, Italo Poggesi, Freya Rasschaert, et al.
Comprehensive Physiology|June 1, 2013
Gap junctionsMorten Schak Nielsen, Lene Nygaard Axelsen, Paul L Sorgen, et al.
Journal of Cardiovascular Pharmacology|April 10, 2015
Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat AtriumLasse Skibsbye, Xiaodong Wang, Lene Nygaard Axelsen, et al.
The Journal of Membrane Biology|June 15, 2007
Increasing gap junctional coupling: a tool for dissecting the role of gap junctionsLene Nygaard Axelsen, Ketil Haugan, Martin Stahlhut, et al.
Cardiovascular Diabetology|January 19, 2013
Myocardial impulse propagation is impaired in right ventricular tissue of Zucker diabetic fatty (ZDF) ratsKristine Boisen Olsen, Lene Nygaard Axelsen, Thomas Hartig Braunstein, et al.
Chest|December 22, 2025
A prospective, multicenter, open-label, single-arm Phase 2 study to investigate the pharmacokinetics, safety, tolerability, and exploratory efficacy of selexipag in children with pulmonary arterial hypertensionMaurice Beghetti, Lene Nygaard Axelsen, Julian I Borissoff, et al.
Scientific Reports|November 21, 2024
Multi-layered proteomics identifies insulin-induced upregulation of the EphA2 receptor via the ERK pathway which is dependent on low IGF1R levelSarah Hyllekvist Jørgensen, Kristina Bennet Emdal, Anna-Kathrine Pedersen, et al.
Cardiovascular Diabetology|July 15, 2015
Diet-induced pre-diabetes slows cardiac conductance and promotes arrhythmogenesisLene Nygaard Axelsen, Kirstine Calloe, Thomas Hartig Braunstein, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
CPT: Pharmacometrics & Systems Pharmacology|November 21, 2024
Population pharmacokinetics of selexipag for dose selection and confirmation in pediatric patients with pulmonary arterial hypertensionLene Nygaard Axelsen, Anne Kümmel, Juan Jose Perez Ruixo, et al.
British Journal of Clinical Pharmacology|May 17, 2020
Clopidogrel, a CYP2C8 inhibitor, causes a clinically relevant increase in the systemic exposure to the active metabolite of selexipag in healthy subjectsLene Nygaard Axelsen, Italo Poggesi, Freya Rasschaert, et al.
Comprehensive Physiology|June 1, 2013
Gap junctionsMorten Schak Nielsen, Lene Nygaard Axelsen, Paul L Sorgen, et al.
Journal of Cardiovascular Pharmacology|April 10, 2015
Antiarrhythmic Mechanisms of SK Channel Inhibition in the Rat AtriumLasse Skibsbye, Xiaodong Wang, Lene Nygaard Axelsen, et al.
The Journal of Membrane Biology|June 15, 2007
Increasing gap junctional coupling: a tool for dissecting the role of gap junctionsLene Nygaard Axelsen, Ketil Haugan, Martin Stahlhut, et al.
Cardiovascular Diabetology|January 19, 2013
Myocardial impulse propagation is impaired in right ventricular tissue of Zucker diabetic fatty (ZDF) ratsKristine Boisen Olsen, Lene Nygaard Axelsen, Thomas Hartig Braunstein, et al.
Chest|December 22, 2025
A prospective, multicenter, open-label, single-arm Phase 2 study to investigate the pharmacokinetics, safety, tolerability, and exploratory efficacy of selexipag in children with pulmonary arterial hypertensionMaurice Beghetti, Lene Nygaard Axelsen, Julian I Borissoff, et al.
Scientific Reports|November 21, 2024
Multi-layered proteomics identifies insulin-induced upregulation of the EphA2 receptor via the ERK pathway which is dependent on low IGF1R levelSarah Hyllekvist Jørgensen, Kristina Bennet Emdal, Anna-Kathrine Pedersen, et al.
Cardiovascular Diabetology|July 15, 2015
Diet-induced pre-diabetes slows cardiac conductance and promotes arrhythmogenesisLene Nygaard Axelsen, Kirstine Calloe, Thomas Hartig Braunstein, et al.
Pageof 1